European perspectives on global health: a policy glossary
European perspectives on global health: a policy glossary European perspectives on global health: a policy glossary
2. Europe must include global health in all fields of policy e-Health ), consumption of services abroad ( patients who travel abroad for medical treatment ), commercial presence ( establishment of health facilities in the country concerned ), and presence of natural persons ( foreign doctors or nurses who seek to practice in other countries ). Informed and evidence-based approaches are needed to manage any future efforts to liberalise health-related services so as to ensure greater access to affordable, better-quality, and effective services, leading to increased choice for consumers and greater equity in health outcomes. In the past, most services were not considered to be tradable across borders. Much has occurred to alter the tradability of services, including health services. Advances in communications technology, including the development of e-commerce, as well as regulatory changes in many parts of the world have made it easier to deliver services across borders. In many countries, changes in government policy have left greater room for the private sector – domestic as well as foreign – to provide services. Partly as a result, services have become the fastest-growing segment of the world economy, providing more than 60 % of global output and employment. Such changes led governments to include services in trade negotiations, resulting in the GATS at the end of the Uruguay Round. GATS takes a gradual approach to trade liberalisation allowing member states to include or exclude services such as health insurance and care. So far, the liberalising effects have remained limited as most WTO Members have made relatively few commitments that go beyond existing levels of access. However, many fear that opening up health markets in developing countries could lead to foreign companies “cherry picking” the most profitable sectors, to the disadvantage of local health services. It goes unnoticed that GATS also provides for the control of the international movement of staff for the provision of services. As the latest World Health Report 2006 points out, the migration of health workers to rich countries is a fundamental cause of poor health and health care in resource-poor countries. Yet at present this provision has not yet been applied to the recruitment of health staff from developing countries to rich regions such as Western Europe. Instead, a weaker form of control is applied through conventions and bilateral agreements that have been very ineffective in stemming the flow of health professional migration. The TBT Agreement on technical barriers to trade can also be relevant to health. WTO rules which govern technical barriers to trade applied for reasons of protecting human health are covered by either the TBT Agreement or the SPS Agreement. Countries face challenges in ensuring compliance with the disciplines of SPS and TBT. This is particularly the case in the areas of food safety, diagnostic devices and medicines’ quality, safety and efficacy, respectively, in which the trade agreement creates obligations to draw up regulations based on science, conduct required risk assessments, and implement international standards through independent and effective national regulatory authorities. All members have the right to restrict trade for “legitimate objectives” under the TBT Agreement. These legitimate objectives include the protection of human health or safety, the protection of animal or plant life or health, the protection of the environment, national security interests, and the prevention of deceptive practices. The TBT Agreement aims to ensure that product requirements, and procedures that are used to assess compliance with those requirements, do not create unnecessary obstacles to trade. The Agreement applies to product requirements that are mandatory ( “technical regulations” ) as well as voluntary ( “standards” ). It covers such requirements developed by governments or private entities, whether at the national or the regional level. The TBT Agreement strongly encourages the use of international standards, such as WHO standards, and where appropriate for these to be adopted as national standards or technical regulations. Members may depart from such international standards if they consider that their application would be ineffective or inappropriate for the fulfilment of certain legitimate objectives. In such cases, Members are free to set standards at a level they consider appropriate, but have to be able to justify their decisions if requested by another Member to do so. The SPS Agreement contains specific rules for countries which want to restrict trade to ensure food safety and the protection of human life from plantor animal-carried diseases ( zoonoses ). Its objective is two-fold : it aims to ( i ) recognise the sovereign 30
2. Europe must include global health in all fields of policy right of Members to determine the level of health protection they deem appropriate ; and ( ii ) ensure that a sanitary or phytosanitary requirement does not represent an unnecessary, arbitrary, scientifically unjustifiable, or disguised restriction on international trade. In order to achieve its objective, the SPS Agreement encourages Members to use international standards, guidelines and recommendations where they exist. Members may adopt SPS measures which result in higher levels of health protection – or measures aimed at health concerns for which international standards do not exist – provided that they are scientifically justified. The SPS Agreement encourages the use of international standards. In the area of food safety, the SPS Agreement explicitly recognises the international standards developed by the joint FAO / WHO Codex Alimentarius Commission. This means that if a government has based its requirement, such as a maximum residue level for a pesticide in a food, on a Codex standard, it is presumed to be meeting its WTO obligations. In the context of sanitary issues such as mad cow disease or avian influenza, the use of SPS has had an increasing impact on EU exports in recent years, prompting the Commission to create a database of SPS exports that provides information on export problems with third countries. EU countries themselves have resorted to using the SPS mechanism. It is expected that this use will increase as other trade barriers are reduced in the future. Trade within the
- Page 2 and 3: This policy glossary was produced w
- Page 4 and 5: 4 European Foundat
- Page 6 and 7: Foreword To enable Europe to play a
- Page 8 and 9: Introduction the expenditures on ar
- Page 10 and 11: 1. Europe must make global health a
- Page 12 and 13: 1. Europe must make global health a
- Page 14 and 15: 1. Europe must make global health a
- Page 16 and 17: 1. Europe must make global health a
- Page 18 and 19: 1. Europe must make global health a
- Page 20 and 21: 2. Europe must include global healt
- Page 22 and 23: 2. Europe must include global healt
- Page 24 and 25: 2. Europe must include global healt
- Page 26 and 27: 2. Europe must include global healt
- Page 28 and 29: 2. Europe must include global healt
- Page 32 and 33: 2. Europe must include global healt
- Page 34 and 35: 2. Europe must include global healt
- Page 36 and 37: 3. Europe must assert its role in g
- Page 38 and 39: 3. Europe must assert its role in g
- Page 40 and 41: 3. Europe must assert its role in g
- Page 42 and 43: 3. Europe must assert its role in g
- Page 44 and 45: 3. Europe must assert its role in g
- Page 46 and 47: 3. Europe must assert its role in g
- Page 48 and 49: 3. Europe must assert its role in g
- Page 50 and 51: 4. Europe must establish a societal
- Page 52 and 53: 4. Europe must establish a societal
- Page 54 and 55: 4. Europe must establish a societal
- Page 56 and 57: 4. Europe must establish a societal
- Page 58 and 59: 4. Europe must establish a societal
- Page 60 and 61: 5. Europe must act now for global h
- Page 62 and 63: 5. Europe must act now for global h
- Page 64 and 65: 5. Europe must act now for global h
- Page 66 and 67: 5. Europe must act now for global h
- Page 68 and 69: 5. Europe must act now for global h
- Page 70: About the Editors Ilona Kickbusch s
2. Europe must include <strong>global</strong> <strong>health</strong> in all fields of <strong>policy</strong><br />
e-Health ), c<strong>on</strong>sumpti<strong>on</strong> of services abroad ( patients<br />
who travel abroad for medical treatment ), commercial<br />
presence ( establishment of <strong>health</strong> facilities in the<br />
country c<strong>on</strong>cerned ), and presence of natural pers<strong>on</strong>s<br />
( foreign doctors or nurses who seek to practice<br />
in other countries ). Informed and evidence-based<br />
approaches are needed to manage any future efforts<br />
to liberalise <strong>health</strong>-related services so as to ensure<br />
greater access to affordable, better-quality, and<br />
effective services, leading to increased choice for<br />
c<strong>on</strong>sumers and greater equity in <strong>health</strong> outcomes.<br />
In the past, most services were not c<strong>on</strong>sidered to be<br />
tradable across borders. Much has occurred to alter<br />
the tradability of services, including <strong>health</strong> services.<br />
Advances in communicati<strong>on</strong>s technology, including<br />
the development of e-commerce, as well as regulatory<br />
changes in many parts of the world have made it<br />
easier to deliver services across borders. In many<br />
countries, changes in government <strong>policy</strong> have left<br />
greater room for the private sector – domestic as well<br />
as foreign – to provide services. Partly as a result,<br />
services have become the fastest-growing segment<br />
of the world ec<strong>on</strong>omy, providing more than 60 % of<br />
<strong>global</strong> output and employment.<br />
Such changes led governments to include services in<br />
trade negotiati<strong>on</strong>s, resulting in the GATS at the end of<br />
the Uruguay Round. GATS takes a gradual approach to<br />
trade liberalisati<strong>on</strong> allowing member states to include<br />
or exclude services such as <strong>health</strong> insurance and care.<br />
So far, the liberalising effects have remained limited<br />
as most WTO Members have made relatively few<br />
commitments that go bey<strong>on</strong>d existing levels of access.<br />
However, many fear that opening up <strong>health</strong> markets in<br />
developing countries could lead to foreign companies<br />
“cherry picking” the most profitable sectors, to the<br />
disadvantage of local <strong>health</strong> services.<br />
It goes unnoticed that GATS also provides for the<br />
c<strong>on</strong>trol of the internati<strong>on</strong>al movement of staff for the<br />
provisi<strong>on</strong> of services. As the latest World Health Report<br />
2006 points out, the migrati<strong>on</strong> of <strong>health</strong> workers to<br />
rich countries is a fundamental cause of poor <strong>health</strong><br />
and <strong>health</strong> care in resource-poor countries. Yet at<br />
present this provisi<strong>on</strong> has not yet been applied to the<br />
recruitment of <strong>health</strong> staff from developing countries<br />
to rich regi<strong>on</strong>s such as Western Europe. Instead, a<br />
weaker form of c<strong>on</strong>trol is applied through c<strong>on</strong>venti<strong>on</strong>s<br />
and bilateral agreements that have been very<br />
ineffective in stemming the flow of <strong>health</strong> professi<strong>on</strong>al<br />
migrati<strong>on</strong>.<br />
The TBT Agreement <strong>on</strong> technical barriers to trade<br />
can also be relevant to <strong>health</strong>. WTO rules which<br />
govern technical barriers to trade applied for reas<strong>on</strong>s<br />
of protecting human <strong>health</strong> are covered by either the<br />
TBT Agreement or the SPS Agreement. Countries face<br />
challenges in ensuring compliance with the disciplines<br />
of SPS and TBT. This is particularly the case in the<br />
areas of food safety, diagnostic devices and medicines’<br />
quality, safety and efficacy, respectively, in which<br />
the trade agreement creates obligati<strong>on</strong>s to draw up<br />
regulati<strong>on</strong>s based <strong>on</strong> science, c<strong>on</strong>duct required risk<br />
assessments, and implement internati<strong>on</strong>al standards<br />
through independent and effective nati<strong>on</strong>al regulatory<br />
authorities.<br />
All members have the right to restrict trade for<br />
“legitimate objectives” under the TBT Agreement.<br />
These legitimate objectives include the protecti<strong>on</strong> of<br />
human <strong>health</strong> or safety, the protecti<strong>on</strong> of animal or<br />
plant life or <strong>health</strong>, the protecti<strong>on</strong> of the envir<strong>on</strong>ment,<br />
nati<strong>on</strong>al security interests, and the preventi<strong>on</strong> of<br />
deceptive practices. The TBT Agreement aims to ensure<br />
that product requirements, and procedures that are<br />
used to assess compliance with those requirements,<br />
do not create unnecessary obstacles to trade. The<br />
Agreement applies to product requirements that<br />
are mandatory ( “technical regulati<strong>on</strong>s” ) as well as<br />
voluntary ( “standards” ). It covers such requirements<br />
developed by governments or private entities, whether<br />
at the nati<strong>on</strong>al or the regi<strong>on</strong>al level.<br />
The TBT Agreement str<strong>on</strong>gly encourages the use of<br />
internati<strong>on</strong>al standards, such as WHO standards,<br />
and where appropriate for these to be adopted as<br />
nati<strong>on</strong>al standards or technical regulati<strong>on</strong>s. Members<br />
may depart from such internati<strong>on</strong>al standards if they<br />
c<strong>on</strong>sider that their applicati<strong>on</strong> would be ineffective or<br />
inappropriate for the fulfilment of certain legitimate<br />
objectives. In such cases, Members are free to set<br />
standards at a level they c<strong>on</strong>sider appropriate, but<br />
have to be able to justify their decisi<strong>on</strong>s if requested<br />
by another Member to do so.<br />
The SPS Agreement c<strong>on</strong>tains specific rules for<br />
countries which want to restrict trade to ensure food<br />
safety and the protecti<strong>on</strong> of human life from plantor<br />
animal-carried diseases ( zo<strong>on</strong>oses ). Its objective<br />
is two-fold : it aims to ( i ) recognise the sovereign<br />
30 <str<strong>on</strong>g>European</str<strong>on</strong>g> Foundati<strong>on</strong> Centre – <str<strong>on</strong>g>European</str<strong>on</strong>g> Partnership for Global Health